The M100 is a 2-wire transmitter for liquid analytics in the pharmaceutical and chemical industries. The M100 is based on a compact head mount design without a local interface.
Expanded line of HydroWhirl Poseidon® nozzles includes lower flow rates from 4.45 GPM to 26.3 GPM. The smaller-sized tank washing nozzles are designed to fit through openings as small as 2”, while maintaining a slow and controlled rotation speed.
ATS Labs is changing its company name to Accuratus Lab Services. ATS Labs recently completed a large acquisition of the assets of Microtest Laboratories enabling it to expand its service offering into the growing medical device and pharmaceutical market segments.
Amgen announced that the FDA has approved a new indication for XGEVA (denosumab) for the treatment of hypercalcemia of malignancy (HCM) refractory to bisphosphonate therapy. XGEVA was approved and granted Orphan Drug Designation by the FDA.
A Kansas airman accused of aggravated assault for exposing multiple sex partners to HIV at swinger parties in Wichita will have his appeal heard this week before the nation's highest military court. The Court of Appeals for the Armed Forces will on Tuesday take up the case against David Gutierrez, an appeal the defense contends could upend similar prosecutions in the U.S. military.
A survey this year by The Physicians Foundation found that 81 percent of doctors describe themselves as either over-extended or at full capacity, and 44 percent said they planned to cut back on the number of patients they see, retire, work part-time or close their practice to new patients.
As health officials struggle to contain the world's biggest-ever Ebola outbreak, their efforts are being complicated by another problem: bad data. Having accurate numbers about an outbreak is essential not only to provide a realistic picture of the epidemic, but to determine effective control strategies.
Sigma-Aldrich Corporation stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany at a special meeting of stockholders.
Puerto Rico's governor says Florida-based pharmaceutical company Romark Laboratories is building a $110M plant in the U.S. territory. Alejandro Garcia Padilla says construction will begin in January and that nearly 200 jobs will be created in three years.
A paralegal recently fired by French drugmaker Sanofi has filed a whistleblower lawsuit, claiming she was discharged after protesting an alleged kickback scheme to increase U.S. sales of its insulin medicines.
Takeda Pharmaceutical Company Limited announced its global oncology business unit, headquartered in Cambridge, MA, will be called Takeda Oncology. The creation of Takeda Oncology will improve the company’s ability to meet the unique and urgent needs of cancer patients.
Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than $55 million to a competing Chinese drug company will no longer face charges, the U.S. attorney's office announced Friday.
Otsuka Pharmaceutical and H. Lundbeck A/S announced that FDA approved the labeling update of Abilify Maintena® for extended-release injectable suspension. The approval was based on results from a controlled clinical study of acutely relapsed adults with schizophrenia.
Dynavax Technologies and AstraZeneca signed an amendment to the existing Research Collaboration and License Agreement under which AstraZeneca will fully fund and Dynavax will conduct a Phase 2a safety and efficacy trial of AZD1419 in patients with asthma.
The claims in the patent cover, among other inventions, Acura's IMPEDE® Technology, a unique polymer matrix that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine. This is the first issued U.S. patent directed at Acura's IMPEDE technology and products utilizing that technology.